Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

19 Jun 2026, 16:45 UTC · 1h ago

Johnson & Johnson (JNJ) Could Be a Great Choice

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Johnson & Johnson's earnings are projected to grow at a year-over-year rate of 7.23% for fiscal year 2026. — Positive earnings growth estimates generally support higher stock valuations and dividend sustainability.
+0.30
2
Johnson & Johnson's current dividend yield of 2.35% is higher than both the Large Cap Pharmaceuticals industry average (2.23%) and the S&P 500 average (1.43%). — A superior yield relative to benchmarks makes the stock more attractive to income-focused investors.
+0.20
3
Johnson & Johnson's dividend payout ratio currently stands at 48% of its trailing 12-month earnings per share. — A payout ratio under 50% suggests the dividend is well-covered and has room for future growth.
+0.10